World Health Organization Director-General Dr. Tedros Adhanom Ghebreyesus presented the Pathogen Access and Benefit Sharing (PABS) annex to the WHO Pandemic Agreement.

This framework aims to prevent the inequities seen during the COVID-19 pandemic by ensuring that countries sharing pathogen data receive fair access to the resulting medical benefits. The system seeks to balance the rapid sharing of biological materials with the guaranteed delivery of vaccines and treatments to all nations.

The PABS system is a critical component of the broader Pandemic Agreement. Member states held a second intergovernmental meeting on the system from Sept. 15-19, 2025 [1]. During these sessions, negotiators worked to finalize the annex to ensure that the sharing of pathogens—the viruses or bacteria that cause disease—is linked to a transparent benefit-sharing mechanism.

Developing nations have historically shared genetic sequences of pathogens only to find themselves unable to afford the vaccines developed from that data. The PABS annex is designed to codify the obligations of both the providers of data and the manufacturers of medical countermeasures.

Despite the progress made during the September sessions, some points of contention remained among member states. To resolve these outstanding issues, member states decided to resume PABS negotiations in January 2026 [2]. These discussions are intended to finalize the legal language of the annex to ensure it is enforceable across different jurisdictions.

Dr. Tedros said the goal is to build a more resilient global health architecture. By establishing a unified system for access and benefit-sharing, the WHO intends to remove the diplomatic and economic hurdles that slowed the global response to previous health emergencies.

“The system seeks to balance the rapid sharing of biological materials with the guaranteed delivery of vaccines.”

The PABS annex represents a shift from voluntary cooperation to a structured legal requirement for pathogen sharing. By tying the sharing of genetic data to the guaranteed receipt of benefits, the WHO is attempting to solve the 'equity gap' that left many low-income countries without vaccines during COVID-19. The success of the January 2026 negotiations will determine if the global community can establish a binding precedent for biological sovereignty and shared medical advancement.